홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

마니디핀

Manidipine

HCID 4008
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
89226-50-6
표준 SMILES
COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1
InChIKey
ANEBWFXPVPTEET-UHFFFAOYSA-N
분자식
C35H38N4O6
평균 분자량
610.7 g/mol
단동위원소 질량
610.27913494

개요

Manidipine is a diarylmethane.

이름 및 식별자

우선 이름
Manidipine
IUPAC
5-O-[2-(4-benzhydrylpiperazin-1-yl)ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
현지명
마니디핀
영어명
Manidipine
분자식
C35H38N4O6
분자량
610.7

이름 및 동의어

manidipine89226-50-6FranidipineArtedilManidipine 63005-O-[2-(4-benzhydrylpiperazin-1-yl)ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylateManidipino6O4754US88DTXSID20437452-(4-Diphenylmethyl-1-piperazinyl)ethyl methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate3-{2-[4-(diphenylmethyl)piperazin-1-yl]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylatemanidipinum
이름 더 보기
마니디핀Manidipine (Manyper)IpertenManidipine(base)Manidipine(CV-4093)Manidipine Impurity1254Manidipine (10mM in DMSO)
3-(2-(4-(diphenylmethyl)piperazin-1-yl)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate5-O-(2-(4-benzhydrylpiperazin-1-yl)ethyl) 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylatemanidipine, (+-)-RefChem:809939DTXCID0023745C08CA11120092-68-43-(2-(4-Benzhydrylpiperazin-1-yl)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

물성

구조 계산 물성

XLogP
5.6
극성 표면적
117 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
9
회전 가능 결합 수
11
무거운 원자 수
45
형식 전하
0
복잡도
1,090

실험 및 물리화학적 성질

DrugsPharmaceuticals
LogP5.2
Solubility<1mg/mL

물리화학적 성질

녹는점
125 · 125-128°C
끓는 점
722 · 722.0±60.0 °C(Predicted)
밀도
1.232 · 1.232±0.06 g/cm3(Predicted)
저장 조건
2 · Sealed in dry,2-8°C
용해도
10 mM · Soluble in DMSO > 10 mM
물리적 상태
가루
산도 계수 (pKa)
6.12 · 6.12±0.10(Predicted)
색상
Light yellow to yellow
LogP
4.135 · 4.135

화학적 성질

Light Yellow Crystalline Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 1 notifications to the ECHA C&L Inventory.

유해성 정보

Regulatory InformationREACH registered substance: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(4-(diphenylmethyl)-1-piperazinyl)ethyl methyl ester (EC: 855-394-4)
Hazard Classes and CategoriesAcute Tox. 3 (100%)

독성 정보

Drug Induced Liver Injury · 4건

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Manidipine

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

안전 데이터

신호 어
Warning
유해·위험 문구
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드 H302

화학 및 산업

약리 정보

ATC Code · 2건

C - Cardiovascular system

QC - Cardiovascular system

Protein BindingManidipine is 99% bound to human plasma proteins.
PharmacodynamicsManidipine produces vasodilation resulting in lower blood pressure.
Mechanism of Action · 1건

Contraction of vascular smooth muscle is stimulated by Gq coupled receptors which produce calcium release from the sarcoplasmic reticulum. This is followed by opening of voltage dependent calcium channels and an influx of calcium into the cell ultimately producing contraction. Manidipine binds to and dissociates slowly from L- and T-type voltage dependent calcium channels on smooth muscle cells, blocking the entrance of extracellular calcium into the cell and preventing this contraction. This produces vasodilation which decreases blood pressure. Manidipine produces renal vasodilation and an increase in natriuresis. This likely contributes to the antihypertensive effect by reducing blood volume. Manidipine is selective for the vasculature and does not produce significant effects on the heart or central nervous system at clinically relevant dosages.

Biological Half-LifeThe half life of elimination has been observed to be dose dependent. Doses of 5, 10, and 20 mg produced half lives of 3.94, 5.02, and 7.95 h respectively.
Metabolism/MetabolitesManidipine is extensively metabolized by CYP enzymes to pyridine derivatives and diphenylmethane derivatives which make up 4-7% and 22-24% of the dose excreted in the urine.
MeSH Pharmacological Classification · 2건

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

관련 반응

2건
반응 기록 만들기
HRID 1475169 반응식
HRID 1475169생성물로
HRID 1475170 반응식
HRID 1475170반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

데이터베이스 식별자

CAS
89226-50-6
PubChem CID
4008
DTXSID
DTXSID2043745
ChEMBL
CHEMBL1085699、CHEMBL312176
ChEBI
CHEBI:135849
UNII
6O4754US88
EC Number
855-394-4
Nikkaji
J313.870D

A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Absorption, Distribution and Excretion · 2건

The median Tmax is 1.5 h. Administration with food produces an 1.3-1.6-fold increase in Cmax but no change in Tmax. Manidipine does not accumulate significantly with multiple doses.

Manidipine is eliminated through extensive metabolism. 63% is eliminated in the feces and 31% in the urine as metabolites.

용도 및 제조

UsesUse (kg; approx.) in Germany (2009): >25
응용 분야 · 2건

개요Manidipine is a dihydropyridine L- and T-type calcium channel blocker. It blocks recombinant rabbit L-type (α1Cα2/δβ1a) and human T-type (α1H) calcium channels expressed in Xenopus oocytes and native L-type channels in dissociated guinea pig cardiac ventricular cells (IC50 = 2.6 nM). Manidipine inhibits intracellular calcium increases induced by endothelin-1 (ET-1; ) in A7r5 rat vascular smooth muscle cells (ED50 = 1 nM) and potassium-induced contraction of isolated dog femoral and portal veins (IC50s = 24 and 2.1 nM, respectively). In vivo, it lowers blood pressure in spontaneously hypertensive rats (SHRs) when administered at a dose of 10 mg/kg and inhibits left ventricular hypertrophy in rats induced by isoproterenol when administered at a dose of 3 mg/kg. Formulations containing manidipine have been used in the treatment of hypertension.

용도Manidipine (Manyper) is a lipophilic, third-generation, highly vasoselective dihydropyridine calcium antagonist with an IC50 of 2.6 nM. It causes systemic vasodilation by inhibiting the voltage-dependent calcium inward currents in smooth muscle cells. It

상·하류 제품 정보

상류 원료

Manidipine아세틸 케텐3-아미노크로톤산메틸매니디핀염산염1-(2-하이드록시에틸)피페라진이소프로필에테르황산마그네슘2-(4-Benzhydrylpiperazino)ethyl acetoacetate1,4-디하이드로-2,6-디메틸-4-(3-니트로페닐)-3,5-피리딘디카르복실산3-메틸에스테르2-(4-벤즈히드릴피페라진-1-일)에탄올Methyl 3-nitrobenzylideneacetoacetate3-니트로벤즈알데히드1-Benzhydrylpiperazine